Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

SPDR® S&P Pharmaceuticals ETF (XPH)

Delayed Data
As of 3:59pm ET
 -1.86 / -1.43%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index. In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.

No recent news for SPDR® S&P Pharmaceuticals ETF.


1 month+4.03% 3 years+35.34%
3 months+8.42% 5 years+29.28%
1 year+43.33% Since inception+19.01%
Data through 08/04/2015

Quote Details

Previous close$130.35
Open day’s range128.04 – 130.54
Net asset value (NAV)130.20 (08/03/2015)
Daily volume64,396
Average volume (3 months)69,195
Data as of 3:59pm ET, 08/04/2015

Peer Comparisonvs. Health ETFs

Performance 5-yr return+29.28%+26.72%
Expense Gross exp ratio0.35%0.47%
Risk 5 year sharpe ratio1.801.74
Net assets$1.1B$2.0B
Average market cap$6.6B$37.5B
Average P/E29.925.5
Dividend / Share--0.21%


XLV Health Care Select Sector SPDR® Fund
VHT Vanguard Health Care Index Fund ETF Shar...
RYH Guggenheim S&P 500® Equal Weight Health...


Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
TTPH Tetraphase Pharmaceuticals Inc3.33%
ANIP ANI Pharmaceuticals Inc3.25%
NKTR Nektar Therapeutics3.20%
HZNP Horizon Pharma PLC3.19%
LCI Lannett Company Inc3.04%
DEPO Depomed Inc3.02%
CEMP Cempra Inc3.00%
PBH Prestige Brands Holdings Inc2.99%
BMY Bristol-Myers Squibb2.97%
AGN Allergan2.96%